IVD Department quantitative AFP testing - Vietnam Registration 2402490ĐKLH/BYT-HTTB
Access comprehensive regulatory information for IVD Department quantitative AFP testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402490ĐKLH/BYT-HTTB. The authorized representative in Vietnam is CÔNG TY TNHH SIEMENS HEALTHCARE.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Theo phụ lục, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2402490ĐKLH/BYT-HTTB
17002498/ĐKLH-BYT-TB-CT
Theo theo phụ lục
Theo phụ lục
Technical Details
- ADVIA Centaur AFP: It is intended for in vitro diagnostic use to determine the concentration of alpha-fetoprotein (AFP) in the following: • human serum and in amniotic fluid from the sample obtained at the time of 15 to 20 weeks of pregnancy, as a supportive test for the detection of open neural tube defects (NTD) when used in combination with ultrasound and amniotic fluid X-ray fluoroscopy, • human serum, to support the management of non-seminomatous testicular cancer by use in combination with clinical examination, histopathology and other clinical evaluation techniques, using the ADVIA Centaur CP, ADVIA Centaur XP and ADVIA Centaur XPT systems. - ADVIA Centaur CAL D: It is intended for in vitro diagnostic use to calibrate the following tests on the ADVIA Centaur system: AFP, CEA.
Dates and Status
Aug 30, 2024